MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.77 Million EUR | -214.15% |
| 2022 | 9.44 Million EUR | 545.98% |
| 2021 | 1.46 Million EUR | 116.18% |
| 2020 | -9.03 Million EUR | -193.51% |
| 2019 | 9.66 Million EUR | 25.2% |
| 2018 | 7.71 Million EUR | 97.46% |
| 2017 | 3.9 Million EUR | -76.38% |
| 2016 | 16.54 Million EUR | 0.06% |
| 2015 | 16.53 Million EUR | 94.47% |
| 2014 | 8.5 Million EUR | 422.35% |
| 2013 | -2.63 Million EUR | -88.02% |
| 2012 | -1.4 Million EUR | -147.12% |
| 2011 | 2.97 Million EUR | -70.52% |
| 2010 | 10.09 Million EUR | -2.5% |
| 2009 | 10.35 Million EUR | 42.42% |
| 2008 | 7.27 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 7.77 Million EUR | 156.99% |
| 2004 | -13.64 Million EUR | 19.53% |
| 2003 | -16.95 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.99 Million EUR | 242.76% |
| 2024 Q1 | -1.39 Million EUR | 94.63% |
| 2023 Q4 | -26.05 Million EUR | -348.03% |
| 2023 Q2 | 11.03 Million EUR | 274.46% |
| 2023 Q3 | 10.5 Million EUR | -4.84% |
| 2023 Q1 | -6.32 Million EUR | -224.28% |
| 2023 FY | -10.77 Million EUR | -214.15% |
| 2022 Q3 | 2.04 Million EUR | -66.76% |
| 2022 FY | 9.44 Million EUR | 545.98% |
| 2022 Q1 | -3.91 Million EUR | -162.36% |
| 2022 Q4 | 5.09 Million EUR | 148.75% |
| 2022 Q2 | 6.15 Million EUR | 257.22% |
| 2021 Q1 | -11.62 Million EUR | -155.86% |
| 2021 Q2 | -3.96 Million EUR | 65.85% |
| 2021 Q3 | 10.77 Million EUR | 371.46% |
| 2021 Q4 | 6.27 Million EUR | -41.72% |
| 2021 FY | 1.46 Million EUR | 116.18% |
| 2020 Q4 | -4.54 Million EUR | -169.23% |
| 2020 FY | -9.03 Million EUR | -193.51% |
| 2020 Q3 | 6.56 Million EUR | 211.22% |
| 2020 Q2 | -5.9 Million EUR | -15.32% |
| 2020 Q1 | -5.11 Million EUR | -231.19% |
| 2019 Q2 | 1.64 Million EUR | 281.28% |
| 2019 Q4 | 3.89 Million EUR | -22.39% |
| 2019 FY | 9.66 Million EUR | 25.2% |
| 2019 Q1 | -908 Thousand EUR | 76.98% |
| 2019 Q3 | 5.02 Million EUR | 205.29% |
| 2018 Q4 | -3.94 Million EUR | -151.9% |
| 2018 FY | 7.71 Million EUR | 97.46% |
| 2018 Q1 | 233 Thousand EUR | 102.05% |
| 2018 Q2 | 3.82 Million EUR | 1542.49% |
| 2018 Q3 | 7.6 Million EUR | 98.59% |
| 2017 Q4 | -11.38 Million EUR | -198.99% |
| 2017 Q3 | 11.5 Million EUR | 148.78% |
| 2017 Q2 | 4.62 Million EUR | 656.99% |
| 2017 Q1 | -830 Thousand EUR | -120.7% |
| 2017 FY | 3.9 Million EUR | -76.38% |
| 2016 Q1 | 854 Thousand EUR | -78.98% |
| 2016 Q2 | 5.43 Million EUR | 536.18% |
| 2016 Q3 | 6.24 Million EUR | 15.02% |
| 2016 Q4 | 4 Million EUR | -35.83% |
| 2016 FY | 16.54 Million EUR | 0.06% |
| 2015 Q4 | 4.06 Million EUR | -50.48% |
| 2015 FY | 16.53 Million EUR | 94.47% |
| 2015 Q3 | 8.2 Million EUR | 135.27% |
| 2015 Q2 | 3.48 Million EUR | 345.91% |
| 2015 Q1 | 782 Thousand EUR | 61.49% |
| 2014 Q2 | 2.7 Million EUR | 254.61% |
| 2014 Q1 | -1.74 Million EUR | -43.45% |
| 2014 Q4 | 484.24 Thousand EUR | -93.15% |
| 2014 Q3 | 7.06 Million EUR | 161.57% |
| 2014 FY | 8.5 Million EUR | 422.35% |
| 2013 Q2 | 887 Thousand EUR | 113.63% |
| 2013 Q4 | -1.21 Million EUR | -129.0% |
| 2013 FY | -2.63 Million EUR | -88.02% |
| 2013 Q1 | -6.5 Million EUR | -68.99% |
| 2013 Q3 | 4.19 Million EUR | 373.39% |
| 2012 Q2 | 960 Thousand EUR | 148.31% |
| 2012 Q3 | 3.43 Million EUR | 257.81% |
| 2012 Q4 | -3.84 Million EUR | -212.08% |
| 2012 FY | -1.4 Million EUR | -147.12% |
| 2012 Q1 | -1.98 Million EUR | -182.64% |
| 2011 Q2 | -1.53 Million EUR | 25.84% |
| 2011 Q4 | 2.4 Million EUR | 14.33% |
| 2011 Q1 | -2.06 Million EUR | -153.81% |
| 2011 FY | 2.97 Million EUR | -70.52% |
| 2011 Q3 | 2.1 Million EUR | 237.45% |
| 2010 Q4 | 3.83 Million EUR | -19.49% |
| 2010 Q3 | 4.76 Million EUR | 53.61% |
| 2010 Q2 | 3.1 Million EUR | 294.24% |
| 2010 Q1 | -1.59 Million EUR | -158.07% |
| 2010 FY | 10.09 Million EUR | -2.5% |
| 2009 Q4 | 2.74 Million EUR | -50.33% |
| 2009 FY | 10.35 Million EUR | 42.42% |
| 2009 Q1 | -1.71 Million EUR | 0.0% |
| 2009 Q3 | 5.53 Million EUR | 46.13% |
| 2009 Q2 | 3.78 Million EUR | 321.46% |
| 2008 FY | 7.27 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 7.77 Million EUR | 156.99% |
| 2004 FY | -13.64 Million EUR | 19.53% |
| 2003 FY | -16.95 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 102.16% |
| Fresenius SE & Co. KGaA | -594 Million EUR | 98.186% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | 417.273% |
| M1 Kliniken AG | 10.27 Million EUR | 204.884% |
| Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | 24.415% |
| RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | 127.837% |
| VITA 34 AG | -1.86 Million EUR | -477.808% |